Autolus Therapeutics (AUTL)
(Real Time Quote from BATS)
$3.52 USD
-0.21 (-5.63%)
Updated Sep 23, 2024 12:24 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Brokerage Reports
0 items in cart
Autolus Therapeutics PLC Sponsored ADR [AUTL]
Reports for Purchase
Showing records 1 - 20 ( 41 total )
Company: Autolus Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Autolus Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Moderna Exercises Option for Proprietary Binder; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: Autolus Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Autolus Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Several Data Updates Slated for EHA; 1Q22 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: Autolus Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Autolus Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
ASH Takeaways; Blackstone Agreement Inked; Modulating PT to $11
Provider: H.C. Wainwright & Co., Inc.
Analyst: BUCK S
Company: Autolus Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Autolus Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Moderna License Could Drive Substantial Upside; 2Q21 Financials; Reit Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: Autolus Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Encouraging AUTO1 Results in Indolent B Cell Lymphomas; 1Q21 Financials Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: Autolus Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
2020 Financial Results; Market Entry Forecast Changes; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: Autolus Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
AUTO1 Prioritized at Expense of AUTO3; Expenses Reduced; Lowering PT to $13
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: Autolus Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
The Next Generation Programmed T Cell Therapy; Assuming at Buy and $19 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: Autolus Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
2Q20 Update; Depth and Breadth of CAR T Platform in Focus at a Relatively Modest EV
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: Autolus Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
A Full Measure to Address Host Rejection
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: Autolus Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
AUTO7; Not Your Grandfather''s CAR T, but Grandpa Could Use It
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: Autolus Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
AUTO1 for Adult ALL - Safety Superior to Blincyto, But Packing the Potent CAR T Punch
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: Autolus Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
In the Battle for the Outpatient Setting - AUTO3 Continues to Present With a Differentiated Profile
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: Autolus Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
AUTO3 Oral Presentation; If Current Trends on Safety and Activity Hold, It Has the Makings of an Outpatient Auto CAR T
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: Autolus Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Heading Into 2H20 With a Plethora of Clinical Readouts
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: Autolus Therapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Market Shudders But We See Names to Outperform.
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department